Terms: = Bone cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
130 results:
1. Assessing egfr-mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy.
Chen WC; Cheng WC; Chen CL; Liao WC; Chen CH; Chen HJ; Tu CY; Lin CC; Hsia TC
Cancer Med; 2024 Apr; 13(7):e7152. PubMed ID: 38549499
[TBL] [Abstract] [Full Text] [Related]
2. Severe megaloblastic anemia in a patient with advanced lung adenocarcinoma during treatment with erlotinib: a case report and literature review.
Yan X; Kong J; Wang J; Wang C; Shen H
BMC Pulm Med; 2024 Mar; 24(1):121. PubMed ID: 38448889
[TBL] [Abstract] [Full Text] [Related]
3. Determinants of bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate cancer in a National Health Care Delivery System.
Nguyen CB; Kobe C; Kumbier KE; Bauman J; Burns JA; Tsao PA; Sparks JB; Skolarus TA; Caram MEV
JCO Oncol Pract; 2024 Jan; 20(1):59-68. PubMed ID: 38085028
[TBL] [Abstract] [Full Text] [Related]
4. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract] [Full Text] [Related]
5. Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung cancer Patients.
Leest PV; Janning M; Rifaela N; Azpurua MLA; Kropidlowski J; Loges S; Lozano N; Sartori A; Irwin D; Lamy PJ; Hiltermann TJN; Groen HJM; Pantel K; Kempen LCV; Wikman H; Schuuring E
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686200
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy of 3rd generation TKI in patients with egfr mutation lung adenocarcinoma with bone metastases: A review of 3 case reports and literature.
Guo Q; Feng W; Hu S; Ye J; Wang S; Su L; Zhang Y; Zhang D; Zhang W; Xu J; Wei Y
Medicine (Baltimore); 2023 Aug; 102(34):e34545. PubMed ID: 37653755
[TBL] [Abstract] [Full Text] [Related]
7. egfr inhibitor-induced folliculitis decalvans: a case series and management guidelines.
Nowaczyk J; Fret K; Kaminska-Winciorek G; Rudnicka L; Czuwara J
Anticancer Drugs; 2023 Sep; 34(8):942-948. PubMed ID: 36708507
[TBL] [Abstract] [Full Text] [Related]
8. HPV Infection is Associated with FoxM1 Overexpression in Dysplastic Changes of Sinonasal Inverted Papilloma.
Rachmadi L; Billianti Susanto YD; Sitinjak D; Manatar AF; Saraswati M; Adham M
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4293-4298. PubMed ID: 36580012
[TBL] [Abstract] [Full Text] [Related]
9. bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
Fanburg-Smith JC; Smith JD; Flemming DJ
Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
[TBL] [Abstract] [Full Text] [Related]
10. De Novo mutation in Epidermal growth factor receptor (egfr)-D761Y responding to third generation tyrosine kinase inhibitor Osimertinib: A case report.
Ding Y; Dong H; Li Y; Liu L; Cai Y; Wang Y; Tian S; Dai C
Medicine (Baltimore); 2022 Jul; 101(29):e29332. PubMed ID: 35866776
[TBL] [Abstract] [Full Text] [Related]
11. Pulmonary Pleomorphic Carcinoma Harboring egfr Mutation Successfully Treated with Osimertinib: A Case Report.
Kano Y; Kataoka N; Kunimatsu Y; Tsutsumi R; Sato I; Tanimura M; Nakano T; Tanimura K; Takeda T
Medicina (Kaunas); 2022 May; 58(6):. PubMed ID: 35743969
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Profile of Lung cancer in Females- A Single Institution Study.
T AK; Visweswaran V; Jayamohanan H; Mehta A; Pavithran K
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443541
[TBL] [Abstract] [Full Text] [Related]
13. Local ablative radiotherapy on oligo-progression while continued on epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer patients: A longer cohort.
Mok FST; Tong M; Loong HH; Mok TSK
Asia Pac J Clin Oncol; 2022 Dec; 18(6):614-624. PubMed ID: 35098663
[TBL] [Abstract] [Full Text] [Related]
14. Secondary myelodysplastic syndromes identified via next-generation sequencing in a non-small cell lung cancer patient.
Feng Y; Chen X; Jiang K; Zhang D; Tao F; Ni D; Zhang J; Wu L; Cai J; Jiang L; Yu G; Shi L
BMC Med Genomics; 2021 Dec; 14(1):299. PubMed ID: 34930266
[TBL] [Abstract] [Full Text] [Related]
15. Contribution of the Idylla
Petiteau C; Robinet-Zimmermann G; Riot A; Dorbeau M; Richard N; Blanc-Fournier C; Bibeau F; Deshayes S; Bergot E; Gervais R; Levallet G
Curr Oncol; 2021 Nov; 28(6):4432-4445. PubMed ID: 34898548
[TBL] [Abstract] [Full Text] [Related]
16. The impact of kidney function on survival in elderly patients diagnosed with acute myeloid leukemia.
Pulko N; Petreski T; Hauptman J; Piko N; Roškar Z; Bevc S
Clin Nephrol; 2021 Suppl; 96(1):31-35. PubMed ID: 34643488
[TBL] [Abstract] [Full Text] [Related]
17. A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired egfr-T790M mutation: a real-world study.
Tang X; Li Y; Qian WL; Yan WF; Pang T; Gong YL; Yang ZG
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2475-2486. PubMed ID: 34536138
[TBL] [Abstract] [Full Text] [Related]
18. [Alectinib for an Octogenarian Patient with Poor Performance Status and ALK Fusion Gene-Positive Lung cancer-A Case Report].
Kamiyoshihara M; Igai H; Matsuura N; Yazawa T; Ohsawa F
Gan To Kagaku Ryoho; 2021 Aug; 48(8):1053-1055. PubMed ID: 34404075
[TBL] [Abstract] [Full Text] [Related]
19. Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis.
Takahara Y; Nakase K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Mizuno S
Cancer Treat Res Commun; 2021; 28():100440. PubMed ID: 34325210
[TBL] [Abstract] [Full Text] [Related]
20. Treatment of Essential Thrombocythemia with Anagrelide Is Associated with an Increased Risk of Worsened Kidney Function.
Kwiatkowski J; Kuliszkiewicz-Janus M; Rymer W; Jaźwiec B; Małecki R
Pharmacology; 2021; 106(5-6):316-322. PubMed ID: 33691325
[TBL] [Abstract] [Full Text] [Related]
[Next]
